Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

One Nucleus Creates a New Membership Category for Those Who Find Themselves Between Life Science Jobs

A Supportive Membership Offer While You Plan Your Next Step

Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.

Coulter Partners places Claus Sundgreen, M.D. as Chief Medical Officer at NRG Therapeutics

LONDON, UK – September 3, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for NRG Therapeutics Ltd. ("NRG") and is pleased to announce the placement of Claus Sundgreen, M.D. as Chief Medical Officer (CMO).

Scaling European Drug Discovery Through Technology, Investment & Collaboration

In March 2027 (date TBC), The Drug Discovery Innovators & Investors event will bring together senior executives, R&D leaders and lab managers from pharma and biotech companies, industry suppliers as well as leaders from academia, start-ups, spin-outs, and the investment community to network and discuss European drug development challenges and opportunities.

Registration will open in early September.
 

2nd Annual BioCentury Grand Rounds - Europe

Bridging Academia and Industry for Breakthrough Innovation

Join top VCs, academic innovators and biopharma leaders at the 2nd Annual BioCentury Grand Rounds - Europe in Amsterdam, Sept. 23-25, 2026.

Examine the latest advances in disease biology, therapeutic modalities and enabling technologies with the experts shaping the future of medicine

Explore how to make R&D investible with experienced company-builders and early-stage investors

Medicines Discovery Catapult invests in UK biotech pioneers developing novel treatments for chronic diseases

Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases

Two UK biotechs developing novel approaches to treating diseases such as psoriasis and Parkinson’s have secured investment and strategic support from Medicines Discovery Catapult (MDC) to accelerate their progress.

Flip Therapeutics and Nascent Therapeutics will each receive £500,000 in funding made available by Innovate UK as part of a scheme that enabled Catapults to invest in high-potential companies.

Technology, Scale, and Capital: Advancing UK Drug Discovery and Development

Join industry leaders, R&D experts, technology suppliers, and investors at the Drug Discovery Innovators & Investors London, UK Conference on 4 November 2026.

The day will explore how technology is reshaping the speed and effectiveness of clinical trials, where early-stage capital is flowing and how companies can access it, and what it takes to build and sustain a resilient, investment-ready drug development business in today’s market.

Subscribe to